Matt DeLisa

Matt DeLisa has a diverse and extensive work experience. Matt is currently a Co-Founder of UbiquiTx, Inc. since 2021. Prior to this, they held multiple positions at Cornell University, including being the Director of Cornell Institute of Biotechnology, William L. Lewis Professor of Engineering, Professor, Associate Professor, and Assistant Professor. Matt was also a Co-Founder of Swiftscale Biologics, Versatope Therapeutics, and Glycobia, Inc. Additionally, they had a Gastprofessur at ETH Zurich and worked as a Postdoc at the University of Texas at Austin.

Matt DeLisa completed their Bachelor of Science in Chemical and Biomolecular Engineering from the University of Connecticut in the years 1991-1996. Matt then pursued further education, earning a PhD in the same field from the University of Maryland between 1996 and 2000.